Full text is available at the source.
Individual efficacy of intermittent preventive treatment with sulfadoxine–pyrimethamine in primi‐ and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight
Effectiveness of preventive malaria treatment with sulfadoxine-pyrimethamine in first and second-time pregnant women in rural Burkina Faso: impact on malaria infection, anemia, and baby weight
AI simplified
Abstract
Two or more doses of sulfadoxine-pyrimethamine significantly reduced the risk of placental parasitaemia and anaemia at delivery.
- Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) is associated with a reduced risk of placental parasitaemia (adjusted odds ratio = 0.04).
- IPTp-SP significantly lowers the risk of anaemia at delivery (adjusted odds ratio = 0.31).
- In primigravidae, IPTp-SP is associated with a reduced risk of low birth weight (adjusted odds ratio = 0.11), while this effect is not observed in secundigravidae.
- Each additional dose of SP is linked to a 1.0% increase in mean packed cell volume at 32 weeks and a 1.2% increase at delivery in primigravidae.
- Mean birth weight increases by 220 g in primigravidae and 102 g in secundigravidae with each additional SP dose.
AI simplified